Agilent Technologies, Inc. $A Stock Sold by ICICI Prudential Asset Management Co Ltd

ICICI Prudential Asset Management Co Ltd decreased its holdings in Agilent Technologies, Inc. (NYSE:A – Free Report) by 58.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 27,105 shares of the medical research company’s stock after selling 38,623 shares during the period. ICICI Prudential Asset Management Co Ltd’s holdings in Agilent Technologies were worth $4,670,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of A. State Street Corp raised its stake in Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after acquiring an additional 89,598 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after acquiring an additional 198,253 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Agilent Technologies by 9.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock valued at $240,336,000 after purchasing an additional 185,223 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. TD Cowen upped their price objective on shares of Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Evercore raised their target price on shares of Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Rothschild & Co Redburn boosted their target price on shares of Agilent Technologies from $160.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Deutsche Bank began coverage on shares of Agilent Technologies in a research note on Monday, October 26th. They set a “buy” rating and a $190.00 target price on the stock. Finally, The Goldman Sachs Group upped their price target on shares of Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a report on Monday, September 21st. Eighteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $181.45.

Get Our Latest Research Report on A

Insider Activity at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.17% of the stock is currently owned by company insiders.

Agilent Technologies Stock Up 0.0%

Shares of NYSE A opened at $173.99 on Monday. The company has a market capitalization of $49.05 billion, a P/E ratio of 34.25, a price-to-earnings-growth ratio of 2.56 and a beta of 1.24. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $182.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The company’s 50 day moving average price is $168.41 and its 200-day moving average price is $138.19.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period last year, the company posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were issued a dividend of $0.2550 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s payout ratio is currently 20.08%.

About Agilent Technologies

(Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Featured Articles

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.